title: Antiviral treatment initiation costs in chronic hepatitis C.
authors.forename: U
authors.initials: U
authors.lastname: Siebert
authors.forename: J
authors.initials: J
authors.lastname: Wasem
authors.forename: S
authors.initials: S
authors.lastname: Rossol
authors.forename: G
authors.initials: G
authors.lastname: Sroczynski
authors.forename: P
authors.initials: P
authors.lastname: Aidelsburger
authors.forename: U
authors.initials: U
authors.lastname: Ravens-Sieberer
authors.forename: B M
authors.initials: BM
authors.lastname: Kurth
authors.forename: M P
authors.initials: MP
authors.lastname: Manns
authors.forename: J G
authors.initials: JG
authors.lastname: McHutchison
authors.forename: J B
authors.initials: JB
authors.lastname: Wong
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003955:Diagnostic Tests, Routine / Q000191:economics; D005858:Germany; D017048:Health Care Costs; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans
chemical_list: D000998:Antiviral Agents